247 related articles for article (PubMed ID: 10664384)
1. Nitric oxide increases the amount of murine cytomegalovirus-DNA in mice latently infected with the virus.
Okada K; Tanaka K; Noda S; Okazaki M; Koga Y
Arch Virol; 1999; 144(12):2273-90. PubMed ID: 10664384
[TBL] [Abstract][Full Text] [Related]
2. Role of nitric oxide in murine cytomegalovirus (MCMV) infection.
Tanaka K; Noda S
Histol Histopathol; 2001 Jul; 16(3):937-44. PubMed ID: 11510985
[TBL] [Abstract][Full Text] [Related]
3. Ocular reactivation of MCMV after immunosuppression of latently infected BALB/c mice.
Zhang M; Xin H; Duan Y; Atherton SS
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):252-8. PubMed ID: 15623781
[TBL] [Abstract][Full Text] [Related]
4. The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs.
Busche A; Marquardt A; Bleich A; Ghazal P; Angulo A; Messerle M
J Virol; 2009 May; 83(9):4030-8. PubMed ID: 19211741
[TBL] [Abstract][Full Text] [Related]
5. Effect of concurrent graft-versus-host reaction on tissue distribution and infectious titer of murine cytomegalovirus.
Cray C; Crouse C; Atherton SS; Levy RB
Arch Virol; 1991; 121(1-4):101-10. PubMed ID: 1662034
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4 protects latently infected mice against murine cytomegalovirus reactivation following allogeneic transplantation.
Gosselin J; Borgeat P; Flamand L
J Immunol; 2005 Feb; 174(3):1587-93. PubMed ID: 15661920
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of cytomegalovirus latency: overview.
Reddehase MJ; Podlech J; Grzimek NK
J Clin Virol; 2002 Aug; 25 Suppl 2():S23-36. PubMed ID: 12361754
[TBL] [Abstract][Full Text] [Related]
8. A novel murine model of differentiation-mediated cytomegalovirus reactivation from latently infected bone marrow haematopoietic cells.
Liu XF; Swaminathan S; Yan S; Engelmann F; Abbott DA; VanOsdol LA; Heald-Sargent T; Qiu L; Chen Q; Iovane A; Zhang Z; Abecassis MM
J Gen Virol; 2019 Dec; 100(12):1680-1694. PubMed ID: 31647403
[TBL] [Abstract][Full Text] [Related]
9. Latent murine cytomegalovirus infection in macrophages.
Pollock JL; Presti RM; Paetzold S; Virgin HW
Virology; 1997 Jan; 227(1):168-79. PubMed ID: 9007070
[TBL] [Abstract][Full Text] [Related]
10. Analysis of target organs for the latency of murine cytomegalovirus DNA using specific pathogen free and germfree mice.
Matsuzawa H; Shimizu K; Okada K; Ando K; Hashimoto K; Koga Y
Arch Virol; 1995; 140(5):853-64. PubMed ID: 7605198
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus.
Koffron AJ; Mueller KH; Kaufman DB; Stuart FP; Patterson B; Abecassis MI
Scand J Infect Dis Suppl; 1995; 99():61-2. PubMed ID: 8668944
[TBL] [Abstract][Full Text] [Related]
12. A model for reactivation of CMV from latency.
Hummel M; Abecassis MM
J Clin Virol; 2002 Aug; 25 Suppl 2():S123-36. PubMed ID: 12361763
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
Cook CH; Zhang Y; Sedmak DD; Martin LC; Jewell S; Ferguson RM
Crit Care Med; 2006 Mar; 34(3):842-9. PubMed ID: 16521279
[TBL] [Abstract][Full Text] [Related]
14. Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR.
Wheat RL; Clark PY; Brown MG
J Virol Methods; 2003 Sep; 112(1-2):107-13. PubMed ID: 12951218
[TBL] [Abstract][Full Text] [Related]
15. Single cell detection of latent cytomegalovirus reactivation in host tissue.
Marquardt A; Halle S; Seckert CK; Lemmermann NAW; Veres TZ; Braun A; Maus UA; Förster R; Reddehase MJ; Messerle M; Busche A
J Gen Virol; 2011 Jun; 92(Pt 6):1279-1291. PubMed ID: 21325477
[TBL] [Abstract][Full Text] [Related]
16. Mouse cytomegalovirus reactivation in severe combined immune deficient mice after implantation of latently infected salivary gland.
Schmader K; Henry SC; Rahija RJ; Yu Y; Daley GG; Hamilton JD
J Infect Dis; 1995 Aug; 172(2):531-4. PubMed ID: 7622898
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide mediates murine cytomegalovirus-associated pneumonitis in lungs that are free of the virus.
Tanaka K; Nakazawa H; Okada K; Umezawa K; Fukuyama N; Koga Y
J Clin Invest; 1997 Oct; 100(7):1822-30. PubMed ID: 9312183
[TBL] [Abstract][Full Text] [Related]
18. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
19. Lungs are a major organ site of cytomegalovirus latency and recurrence.
Balthesen M; Messerle M; Reddehase MJ
J Virol; 1993 Sep; 67(9):5360-6. PubMed ID: 8394453
[TBL] [Abstract][Full Text] [Related]
20. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
Yuhasz SA; Dissette VB; Cook ML; Stevens JG
Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
